Editorial Comment: Urethral Adenocarcinoma: A Rare Malignancy With Poor Oncologic Outcomes Despite Neoadjuvant Treatment and Consolidative Therapy
Open Access
- 1 May 2025
- journal article
- editorial
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 3 (5)
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Updates to Microhematuria: AUA/SUFU Guideline (2025)Journal of Urology, 2025
- Urethral Adenocarcinoma: A Rare Malignancy With Poor Oncologic Outcomes Despite Neoadjuvant Treatment and Consolidative TherapyJU Open Plus, 2025
- Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancyUrologic Oncology: Seminars and Original Investigations, 2019
- Defining the Prevalence of Asymptomatic Microscopic Hematuria Among Women With Symptomatic Pelvic Organ Prolapse: Implications for Recommending Subsequent Diagnostic EvaluationUrology, 2017